COVID-19 vaccination in children: a public health priority

COVID-19 vaccination in children: a public health priority

Objective: Covid-19 had a direct impact on children's health. The aim of this review was to analyze epidemiological and clinical data, the consequences of the pandemic, and vaccination aspects in this group. Sources of data: The searches were carried out from January 2020 to November 2022, in t...

Full description

Bibliographic Details
Main Authors:	Eduardo Jorge da Fonseca Lima, Robério Dias Leite
Format:	Article
Language:	English
Published:	Elsevier 2023-03-01
Series:	Jornal de Pediatria
Subjects:	COVID-19 Pediatric multisystem inflammatory disease COVID-19 related COVID-19 vaccines Myocarditis Vaccine adverse event
Online Access:	http://www.sciencedirect.com/science/article/pii/S0021755722001346

Similar Items

Multisystem inflammatory syndrome and lymphohistiocytic myocarditis after Covid‐19 vaccine in a middle‐aged woman
by: Kosuke Kobayashi, et al.
Published: (2023-04-01)

Myocarditis following COVID-19 mRNA vaccinations: Twin and sibling case series
by: P. Shenton, et al.
Published: (2023-08-01)

Post-mRNA COVID-19 Vaccination Myocarditis
by: Abhishek Matta, et al.
Published: (2021-08-01)

Myocarditis After COVID‐19 Vaccination in Pediatrics: A Proposed Pathway for Triage and Treatment
by: Nefthi Sandeep, et al.
Published: (2022-11-01)

Case report: Myocarditis following COVID-19 protein subunit vaccination
by: Yi-ming Dong, et al.
Published: (2022-09-01)

Multisystem inflammatory syndrome in children (MIS-C) secondary to COVID-19 mRNA vaccination – A case report from Qatar
by: Manoj Varghese, et al.
Published: (2022-01-01)

Myopericarditis in a Male Adolescent Following the Second Shot of COVID-19 Pfizer m-RNA Vaccine: Typical Example and Analysis of 110 Single Case Reports
by: Alessandra Piras, et al.
Published: (2022-09-01)

The incidence and clinical characteristics of myocarditis and pericarditis following mRNA-based COVID-19 vaccination in Republic of Korea adolescents from July 2021 to September 2022
by: Ju-Young Sim, et al.
Published: (2023-04-01)

Clinical Profiles and CMR Findings of Young Adults and Pediatrics with Acute Myocarditis Following mRNA COVID-19 Vaccination: A Case Series
by: Roberto Manfredi, et al.
Published: (2022-01-01)

Parametric Mapping Cardiac Magnetic Resonance Imaging for the Diagnosis of Myocarditis in Children in the Era of COVID-19 and MIS-C
by: Bibhuti B. Das, et al.
Published: (2022-07-01)

Rare Heterogeneous Adverse Events Associated with mRNA-Based COVID-19 Vaccines: A Systematic Review
by: Rana I. Oueijan, et al.
Published: (2022-08-01)

Vaccine‐Triggered Acute Autoimmune Myocarditis: Defining, Detecting, and Managing an Apparently Novel Condition
by: Saidi A. Mohiddin, et al.
Published: (2022-11-01)

Uneventful COVID-19 Infection and Vaccination in a Cohort of Patients with Prior Myocarditis
by: Anna Baritussio, et al.
Published: (2023-11-01)

Myocarditis/pericarditis following vaccination with BNT162b2, CoronaVac, and ChAdOx1 among adolescent and adult in Malaysia
by: Norazida Ab Rahman, et al.
Published: (2023-08-01)

Multisystem inflammatory syndrome in children during the COVID-19 waves: data from the Juvenile Inflammatory Rheumatism cohort
by: Robin Kechiche, et al.
Published: (2023-05-01)

Clinical profile and outcome of pediatric inflammatory multisystem syndrome temporally associated with severe acute respiratory syndrome coronavirus 2 series in Eastern India
by: Bonny Sen, et al.
Published: (2022-01-01)

Myocarditis Following COVID-19 Vaccine Use: Can It Play a Role for Conditioning Immunization Schedules?
by: Susanna Esposito, et al.
Published: (2022-06-01)

COVID-19 Vaccination in Pediatrics: Was It Valuable and Successful?
by: Mohamed Ahmed Raslan, et al.
Published: (2023-01-01)

Adverse Events to Comirnaty Vaccine Are Linked to Sex, Age and BMI: Should We Consider Reducing the Dose for Females?
by: Elena Azzolini, et al.
Published: (2023-02-01)

Psychiatric adverse events reported after COVID-19 vaccination in the European Union (EU), the United States (US) and the United Kingdom (UK)
by: D. Macias Saint-Gerons, et al.
Published: (2022-06-01)

Analysis of participant-reported adverse events following the first dose of inactivated SARS-Cov-2 vaccine (TURKOVAC™) through telephone survey in Türkiye
by: Ateş Kara, et al.
Published: (2023-12-01)

Otorhinolaryngologic complications after COVID-19 vaccination, vaccine adverse event reporting system (VAERS)
by: Jieun Shin, et al.
Published: (2024-01-01)

Adverse Events Profile of COVID-19 Preventative Strategies
by: Kunal M. Ajmera
Published: (2022-02-01)

COVID-19 mRNA Vaccines: The Molecular Basis of Some Adverse Events
by: Girolamo Giannotta, et al.
Published: (2023-03-01)

COVID Vaccine-Associated Myocarditis in Adolescent Siblings: Does It Run in the Family?
by: Julia Moosmann, et al.
Published: (2022-04-01)

A case of myocarditis after COVID-19 vaccination: incidental or consequential?
by: Leona S. Alizadeh, et al.
Published: (2022-06-01)

Myocarditis and Pericarditis following COVID-19 Vaccination in Thailand
by: Chayanit Mahasing, et al.
Published: (2023-03-01)

COVID-19 vaccinations for patients with epilepsy in Guizhou Province, China: A cross-sectional study
by: Qian Zheng, et al.
Published: (2024-04-01)

COVID-19 Vaccine-Induced Myocarditis and Pericarditis: Towards Identification of Risk Factors
by: Laura C. Zwiers, et al.
Published: (2023-07-01)

Vaccine Adverse Events Following COVID-19 Vaccination with Inactivated Vaccines in Zimbabwe
by: Azure Tariro Makadzange, et al.
Published: (2022-10-01)

Correction: COVID-19 Vaccine-Induced Myocarditis and Pericarditis: Towards Identification of Risk Factors
by: Laura C. Zwiers, et al.
Published: (2024-01-01)

Approaches to SARS-CoV-2 and other vaccinations in children with a history of multisystem inflammatory syndrome (MIS-C): An international survey
by: Francesca Minoia, et al.
Published: (2022-11-01)

Active surveillance of adverse events following the first dose of COVID-19 vaccination – Oxford–AstraZeneca (Covishield) vaccine
by: Sangeetha Merrin Varghese, et al.
Published: (2022-01-01)

Myocarditis and Pericarditis Following mRNA COVID-19 Vaccination: What Do We Know So Far?
by: Bibhuti B. Das, et al.
Published: (2021-07-01)

Myocarditis following AstraZeneca (an adenovirus vector vaccine) COVID‐19 vaccination: A case report
by: Shakiba Hassanzadeh, et al.
Published: (2022-04-01)

Adverse events following vaccination against coronavirus disease 2019
by: Minji Jeon, et al.
Published: (2022-03-01)

Serious complications of COVID-19 vaccines: A mini-review
by: Paraskevi C. Fragkou, et al.
Published: (2021-12-01)

Multisystem Inflammatory Syndrome (MIS) following SARS-CoV-2 vaccinations; a systematic review
by: Mohamed Elsaid, et al.
Published: (2023-11-01)

Vaccine Side Effects in Health Care Workers after Vaccination against SARS-CoV-2: Data from TüSeRe:exact Study
by: Alan Bareiß, et al.
Published: (2022-12-01)

Cataracts in setting of multisystem inflammation after COVID-19 vaccination
by: Diana H. Kim, et al.
Published: (2022-09-01)